In addition, Pip treatment can prevent obesity and improve lipid metabolism by regulating adipose tissue expansion (ATE) related genes Sfrp5, MEST, PTRF/Cavin1 [47]. The gene discussed is SFRP5; the disease is obesity due to melanocortin 4 receptor deficiency.